New drug combo tested for Tough-to-Treat cancers
Disease control
Not yet recruiting
This study is testing a new drug, WGI-0301, given together with an existing immunotherapy drug called nivolumab. It aims to see if this combination is safe and shows early signs of helping people with advanced liver cancer or advanced kidney cancer that has stopped responding to …
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC